Clinical Trial Update: RUSSE / Russian Spiriva® Safety & Efficacy Study

View source ↗

Summary

This is a completed Russian safety and efficacy study of Spiriva (tiotropium) for COPD. The trial results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: COPD | Status: COMPLETED | Results posted: 2010-01-18